Sartorius (OTCMKTS:SARTF – Get Free Report)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $217.65, but opened at $192.43. Sartorius shares last traded at $192.43, with a volume of 45 shares changing hands.
Sartorius Stock Performance
The company has a debt-to-equity ratio of 0.89, a current ratio of 0.95 and a quick ratio of 0.49. The company has a market cap of $6.59 billion, a price-to-earnings ratio of 89.50 and a beta of 0.98. The firm has a 50 day simple moving average of $215.11 and a 200-day simple moving average of $221.38.
About Sartorius
Sartorius AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.
The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies.
Read More
- Five stocks we like better than Sartorius
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.
